American Society of Hematology

Highlights of ASH

Attend one of eight Highlights of ASH meetings featuring expert analysis of the 56th ASH Annual Meeting abstracts and sessions.

Learn more

CME Credit and Certificate of Attendance

Obtain CME credit and a certificate of attendance for the 56th ASH Annual Meeting by April 17, 2015.

Learn more

ASH Meeting on Hematologic Malignancies

Hear top experts in hematologic malignancies discuss the latest developments in clinical care.

Learn more

Protect Medical Research

Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to medical research.

Take action
Find a Hematologist

Find a Hematologist

Search a database of practicing hematologists in your area.

Learn more
Support Hematology

ASH Foundation

Help move hematology forward by supporting research, career development, and quality care and education programs.

Learn more
Join ASH

ASH Membership

Become part of a global network of more than 16,000 hematologists working to conquer blood diseases.

Learn more
View all press releases
  • ODAC Recommends Approval of First Biosimilar Drug

    The Oncologic Drugs Advisory Committee (ODAC) of the Food and Drug Administration (FDA) recommended the approval of the first application for a biosimilar drug on January 7.  The panel recommended that FDA approve the application for a biologic agent similar to filgrastim.  This drug would be used for a number of applications in hematology.

  • Medicare Begins Paying for Chronic Care Management

    On January 1, 2015, the Medicare program took a significant step towards recognizing that the role of a physician goes well beyond time in the exam room.  For the first time, Medicare will begin paying physicians for chronic care management.  ASH is pleased that Medicare is finally paying for this service, but still has concerns over the coding and billing requirements.  Read more to learn how this could affect hematology.

  • Highlights from the 2014 APP Lunch

    The ASH Practice Partnership (APP) hosted its annual luncheon event at the 2014 ASH Annual Meeting in San Francisco on Sunday, December 7. This year's topic was "Whither the Practice of Hematology in an Era of Mergers?" Read more to hear about the speakers and presentation.

  • SGR – Where Do We Go from Here?

    As the 113 th Congress winds down, it has become clear that this group of legislators will not be remembered as the one that permanently addressed the issues associated with Medicare physician payment.  Read more to find out what may happen with the SGR in 2015.

View all policy news
  • November-December Editor's Choice

    Dr. Bob Löwenberg (Editor-in-Chief) and Dr. Nancy Berliner (Deputy Editor-in-Chief) have combined efforts to identify some of the most outstanding Blood articles that have appeared either in print or online during the two-month interval between issues of The Hematologist. The goal is to underscore the remarkable research that is published in Blood and to highlight the exciting progress that is being made in the field.

  • Aplastic Anemia and Advocacy for Some Uniquely Pediatric Issues

    Dr. Bertuch and Dr. Kurre examine the need for improvement in how acquired aplastic anemia is both diagnosed and treated in the United States.

  • ASH Launches New Publication for Clinicians

    This fall, ASH will begin publishing a monthly news magazine specifically designed to appeal to clinical practitioners in hematology and oncology. ASH Clinical News will provide timely updates in the field by reporting on key medical meetings, clinical trials, innovative technology, and influential papers in the literature.

  • Looking Back – Looking Forward: 40 Years in Hemophilia Research

    Dr. Gilbert White chronicles his involvement in the HIV and HCV epidemics that devastated the hemophilia population in the 1980s, highlighting the power of science and the resilience of patients, physicians, and scientists, who faced adversity and triumphed.

View all Hematologist articles